# Why is mother’s health essential during and after pregnancy?
Maternal health represents one of the most critical aspects of public health, yet it remains surprisingly overlooked in many healthcare systems worldwide. The physiological journey through pregnancy, childbirth, and the postnatal period places extraordinary demands on a woman’s body, requiring careful monitoring, appropriate nutrition, and comprehensive medical support. Despite significant advances in obstetric care, maternal mortality and morbidity continue to pose substantial challenges, with most deaths occurring within the first six weeks after delivery. Understanding the profound physiological changes that occur during pregnancy, recognising the importance of adequate nutritional support, and ensuring access to quality antenatal and postnatal care are fundamental to safeguarding maternal wellbeing and establishing the foundation for healthy child development.
The relationship between maternal health and long-term outcomes extends far beyond the immediate pregnancy period. Research consistently demonstrates that complications during pregnancy can serve as predictive markers for future cardiovascular disease, metabolic disorders, and other chronic conditions. Pregnancy acts as a physiological stress test, revealing underlying vulnerabilities that may manifest as serious health conditions in later life. This reality underscores the necessity of viewing maternal health not as an isolated event but as an integral component of lifelong healthcare for women.
## Physiological Changes During Pregnancy: Cardiovascular and Metabolic Adaptations
Pregnancy triggers remarkable physiological adaptations that enable the maternal body to support foetal growth and development whilst maintaining its own homeostasis. These changes affect virtually every organ system, with particularly significant alterations occurring in cardiovascular and metabolic function. The magnitude of these adaptations is substantial, and understanding them is essential for identifying pathological deviations that require medical intervention.
### Plasma Volume Expansion and Cardiac Output Increase
One of the most striking cardiovascular changes during pregnancy is the expansion of plasma volume, which increases by approximately 40-50% by the third trimester. This haemodilution serves multiple physiological purposes, including compensating for blood loss during delivery and facilitating nutrient and oxygen transport to the foetus. Accompanying this volume expansion, cardiac output increases by 30-50%, achieved through both elevated heart rate and increased stroke volume. These adaptations begin remarkably early, with measurable changes evident by six weeks of gestation.
The cardiovascular system must work considerably harder throughout pregnancy, placing stress on the heart and blood vessels. Women with pre-existing cardiac conditions face heightened risks during this period, necessitating specialist cardio-obstetric care. Even in healthy pregnancies, the increased cardiac workload can unmask subclinical heart disease, emphasising the importance of thorough cardiovascular assessment during antenatal screening.
### Gestational Diabetes Mellitus: Insulin Resistance and Glucose Metabolism
Pregnancy induces a state of progressive insulin resistance, particularly in the second and third trimesters, as placental hormones such as human placental lactogen, cortisol, and progesterone interfere with insulin signalling. This physiological insulin resistance ensures adequate glucose availability for the developing foetus, whose energy demands increase substantially as pregnancy progresses. However, when the maternal pancreas cannot produce sufficient insulin to overcome this resistance, gestational diabetes mellitus (GDM) develops.
GDM affects approximately 2-10% of pregnancies globally, with considerable variation based on population characteristics and diagnostic criteria. The condition carries significant implications for both maternal and foetal health, including increased risks of macrosomia, birth trauma, neonatal hypoglycaemia, and caesarean delivery. For mothers, GDM represents a critical warning sign for future type 2 diabetes, with affected women facing a seven-fold increased risk of developing the condition later in life. This connection highlights pregnancy as a valuable window for identifying women at elevated metabolic risk.
### Haemodynamic Alterations and Blood Pressure Regulation
Blood pressure typically decreases during early pregnancy due to reduced systemic vascular resistance, reaching its nadir during the second trimester before gradually returning towards pre-pregnancy levels. This physiological reduction results from vasodilation mediated by pregnancy hormones, particularly progesterone and oestrogen, alongside increased production of vasodilatory prostaglandins and nitric oxide. Understanding this normal pattern is crucial for identifying hypertensive disorders of pregnancy.
Pre-eclampsia, characterised by new-onset hypertension and proteinuria after 20 weeks of gestation, represents a serious departure from normal haemodynamic adaptation. Affecting 2-8%
of pregnancies worldwide, it is a leading cause of maternal and perinatal morbidity and mortality. Beyond immediate risks such as eclampsia, placental abruption and preterm birth, pre-eclampsia has long-term implications: women who experience it have an increased lifetime risk of chronic hypertension and cardiovascular disease. Early recognition, regular blood pressure monitoring, and timely referral to specialist care are therefore essential elements of antenatal surveillance and maternal health protection.
Thyroid function changes and hormonal fluctuations
Thyroid function undergoes notable changes during pregnancy due to rising levels of human chorionic gonadotropin (hCG) and oestrogen. hCG has a weak thyroid-stimulating effect, which can cause a transient decrease in thyroid-stimulating hormone (TSH) in early pregnancy, while increased oestrogen elevates thyroid-binding globulin, altering circulating thyroid hormone levels. For most women, these shifts remain within physiological limits, but in those with underlying thyroid disease, pregnancy can unmask or exacerbate dysfunction.
Both overt hypothyroidism and hyperthyroidism are associated with adverse outcomes, including miscarriage, preterm birth, pre-eclampsia, and impaired foetal neurodevelopment. Consequently, appropriate screening in high-risk women and careful dose adjustment of thyroid hormone replacement or antithyroid drugs are crucial. From a broader perspective, these hormonal fluctuations underscore why maternal health during pregnancy must be actively managed rather than passively observed.
Nutritional requirements for maternal health: micronutrients and macronutrients
Optimal nutrition is a cornerstone of maternal health during and after pregnancy. The growing foetus draws heavily on maternal nutrient stores, and inadequate intake can compromise both maternal wellbeing and foetal development. Rather than “eating for two”, the focus should be on nutrient-dense choices that provide sufficient micronutrients and macronutrients to support increased metabolic demands, tissue growth, and postpartum recovery.
Dietary counselling during antenatal care offers a valuable opportunity to prevent deficiencies such as iron deficiency anaemia, folate insufficiency, and low vitamin D status. At the same time, balanced macronutrient intake – including complex carbohydrates, high-quality protein, and healthy fats – helps to maintain stable blood glucose levels and healthy gestational weight gain. By prioritising maternal nutrition, we can significantly influence pregnancy outcomes and long-term health for both mother and child.
Folate supplementation and neural tube defect prevention
Folate, or vitamin B9, plays a critical role in DNA synthesis and cell division, making it essential during the early weeks of pregnancy when organ systems begin to form. Inadequate folate status is strongly associated with neural tube defects (NTDs) such as spina bifida and anencephaly. Because the neural tube closes by the fourth week of gestation – often before a woman realises she is pregnant – preconception folic acid supplementation is vital.
Most guidelines recommend that women planning pregnancy take 400 micrograms of folic acid daily, increasing to 5 milligrams in high-risk groups, such as those with a previous NTD-affected pregnancy or certain medical conditions. In many countries, public health strategies also include folic acid fortification of staple foods to reduce population-wide NTD rates. Viewing folate supplementation as part of routine reproductive health rather than an optional extra helps safeguard maternal health and foetal development from the outset.
Iron deficiency anaemia: haemoglobin optimisation strategies
Iron requirements rise substantially in pregnancy due to expanding maternal blood volume, growth of the foetus and placenta, and preparation for blood loss at delivery. When these increased demands are not met through diet or supplementation, iron deficiency anaemia can develop, affecting up to 40% of pregnant women in some regions. Symptoms such as fatigue, breathlessness and palpitations can easily be dismissed as “normal” pregnancy complaints, but untreated anaemia is linked with preterm birth, low birth weight, and impaired maternal recovery.
Haemoglobin optimisation strategies typically include routine screening in early and mid-pregnancy, dietary counselling to increase iron-rich foods, and oral iron supplementation where needed. In cases of severe anaemia or intolerance to oral preparations, intravenous iron therapy may be indicated. By proactively managing iron status, we not only improve maternal energy levels and quality of life but also reduce the risk of complications during birth and the postpartum period.
Calcium and vitamin D for skeletal health and foetal development
Calcium and vitamin D are fundamental for the development of the foetal skeleton and the maintenance of maternal bone health. During pregnancy, calcium transfer to the foetus increases dramatically, particularly in the third trimester. If dietary intake is insufficient, the maternal skeleton may be resorbed to meet foetal needs, potentially compromising long-term bone density. Vitamin D facilitates intestinal calcium absorption and plays a role in immune function and muscle health.
Women with low sun exposure, darker skin pigmentation, or limited intake of vitamin D–rich foods are at particular risk of deficiency. Supplementation with vitamin D, alongside adequate dietary or supplemental calcium, is often recommended to achieve optimal levels. You can think of these nutrients as the “scaffolding” that supports both mother and baby: without sturdy scaffolding, the structure may stand, but it is far more vulnerable to damage.
Omega-3 fatty acids: DHA and EPA for neurological development
Long-chain omega-3 fatty acids, particularly docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), contribute significantly to foetal brain and retinal development. DHA accumulates rapidly in the foetal brain during the last trimester and early postnatal period, and insufficient maternal intake has been associated with suboptimal neurocognitive outcomes in some studies. Moreover, higher omega-3 consumption may help reduce the risk of preterm birth and support maternal mental health.
Good dietary sources of DHA and EPA include oily fish such as salmon, sardines and mackerel, though intake should be balanced with guidance on mercury exposure. For women who do not consume fish, algae-based supplements can provide a suitable alternative. Integrating omega-3 intake into everyday meals – for example, by including fish twice weekly – is a practical way to support neurological development and maternal wellbeing.
Antenatal care protocols: screening and monitoring standards
Structured antenatal care protocols play a central role in protecting maternal health during pregnancy. By following evidence-based screening and monitoring standards, healthcare providers can identify complications early, initiate timely interventions, and offer personalised guidance. Rather than a series of isolated appointments, antenatal care should be viewed as an ongoing partnership between the pregnant woman and her care team, focused on promoting a safe and positive pregnancy experience.
Standardised schedules typically include routine blood tests, blood pressure checks, urine analysis, and targeted ultrasound examinations. These assessments are complemented by lifestyle counselling, vaccination where appropriate, and mental health screening. When implemented consistently and equitably, antenatal care can significantly reduce maternal and perinatal morbidity and mortality.
First trimester combined screening: NT scan and biochemical markers
The first trimester combined screening test integrates an ultrasound measurement of nuchal translucency (NT) with maternal serum biochemical markers, usually between 11 and 14 weeks of gestation. This approach estimates the risk of chromosomal abnormalities such as trisomy 21 (Down syndrome), trisomy 18 and trisomy 13. While it does not provide a definitive diagnosis, it helps identify pregnancies that may benefit from further testing, such as non-invasive prenatal testing (NIPT) or diagnostic procedures like chorionic villus sampling.
For many families, this screening raises important ethical and emotional questions, making sensitive, non-judgemental counselling essential. From a maternal health perspective, early identification of certain foetal conditions can guide monitoring and delivery planning, and in some cases, highlight additional risks for the mother herself. As with all screening, informed consent and clear communication of benefits and limitations are key.
Glucose tolerance testing: OGTT at 24-28 weeks gestation
The oral glucose tolerance test (OGTT) performed at 24–28 weeks of gestation is the standard method for diagnosing gestational diabetes mellitus in many healthcare systems. After an overnight fast, the woman consumes a glucose drink, and blood samples are taken at specified intervals to assess how effectively her body processes the sugar. Abnormal results indicate impaired glucose tolerance or GDM, prompting closer metabolic monitoring and targeted management.
Timely diagnosis through OGTT allows for interventions such as dietary modification, physical activity guidance, and, when necessary, insulin or oral hypoglycaemic therapy. Without this structured screening, many cases of GDM would remain undetected, increasing the risk of complications for both mother and baby. In this way, the OGTT serves as an important checkpoint in the broader framework of maternal metabolic health.
Foetal growth assessment: Symphysis-Fundal height and ultrasound biometry
Monitoring foetal growth is central to antenatal care, as deviations from expected patterns can signal underlying maternal or placental problems. Symphysis-fundal height (SFH) measurement, taken from the pubic symphysis to the top of the uterine fundus, provides a simple, low-cost screening tool to estimate gestational growth. When SFH measurements fall outside expected ranges, targeted ultrasound biometry is usually undertaken to assess parameters such as head circumference, abdominal circumference and femur length.
Growth restriction may indicate placental insufficiency, maternal hypertension, or other systemic conditions, while excessive growth can be associated with maternal diabetes or obesity. By systematically tracking these measurements over time, clinicians can tailor surveillance and delivery planning to minimise risks. For mothers, understanding these assessments can make the process feel less mysterious and more like a collaborative effort to ensure their baby’s wellbeing.
Pre-eclampsia detection: proteinuria and hypertensive disorders monitoring
Effective detection of pre-eclampsia relies on regular monitoring of blood pressure and urine protein throughout pregnancy. Persistent hypertension (≥140/90 mmHg) after 20 weeks, particularly when accompanied by proteinuria or organ dysfunction, should raise immediate concern. Simple urine dipstick tests provide an initial screen for protein, while more precise assessments such as urine protein:creatinine ratio or 24-hour urine collection confirm the diagnosis.
Early recognition enables closer surveillance, pharmacological management of blood pressure, and timely decisions about the timing and mode of birth. Women with a history of pre-eclampsia may benefit from low-dose aspirin and other preventive measures in subsequent pregnancies. Given the strong association between hypertensive disorders of pregnancy and future cardiovascular risk, this monitoring also lays the groundwork for long-term follow-up of maternal health.
Mental health in the perinatal period: psychological wellbeing assessment
While physical health often dominates discussions of pregnancy and postpartum care, maternal mental health is equally vital. The perinatal period – spanning pregnancy through the first year after birth – is a time of profound emotional, social and hormonal change. Without appropriate support, women may experience depression, anxiety, post-traumatic stress, or in rare cases, psychosis, all of which can affect attachment, infant development and family dynamics.
A proactive approach to psychological wellbeing includes routine screening, open conversations about mood and coping, and clear pathways to specialised support. Rather than expecting mothers to “just get on with it”, healthcare systems and communities must recognise that asking for help is a sign of strength, not inadequacy. When maternal mental health is prioritised, the benefits extend to babies, partners and the wider family unit.
Antenatal depression screening: edinburgh postnatal depression scale implementation
The Edinburgh Postnatal Depression Scale (EPDS) is a widely used, validated questionnaire designed to identify symptoms of depression in the perinatal period. Although originally developed for postpartum use, it is now frequently applied during pregnancy as well. Comprising 10 items that explore mood, enjoyment, anxiety and thoughts of self-harm, the EPDS offers a quick, accessible way to flag women who may need further assessment.
Implementing EPDS screening at several key points in pregnancy and after birth helps normalise conversations about mental health. When a raised score is identified, clinicians can explore the context in more depth, consider contributory factors such as intimate partner violence or social isolation, and arrange appropriate interventions. In everyday terms, the EPDS functions like a “smoke alarm” – it does not diagnose the fire, but it alerts us that something may need urgent attention.
Postnatal psychosis risk factors and early intervention
Postnatal psychosis is a rare but severe psychiatric emergency that typically develops within the first two weeks after childbirth. Symptoms can include extreme mood swings, confusion, hallucinations, delusional beliefs, and disorganised behaviour. Women with a personal or family history of bipolar disorder or previous postpartum psychosis are at particularly high risk, as are those with certain severe mood disorders.
Early intervention is critical to protect both mother and baby. This begins with antenatal identification of women at increased risk and the development of a clear postpartum care plan, including rapid access to specialist perinatal mental health services. Partners and family members should be informed about warning signs and encouraged to seek urgent help if they notice dramatic changes in behaviour or thinking. With timely treatment – often in a mother-and-baby unit – many women make a full recovery.
Anxiety disorders during pregnancy and the postpartum period
Anxiety disorders are at least as common as depression in the perinatal period, yet they often receive less attention. Generalised anxiety, panic disorder, obsessive–compulsive symptoms and birth-related post-traumatic stress can significantly impair daily functioning and enjoyment of early parenthood. Some women may constantly worry about their baby’s health or their own competence, while others experience intrusive thoughts that they find deeply distressing.
Non-pharmacological interventions such as cognitive behavioural therapy (CBT), mindfulness-based approaches and peer support groups can be highly effective and are often preferred as first-line treatments. In moderate to severe cases, medication may be considered, with careful weighing of risks and benefits for both mother and baby. By openly addressing perinatal anxiety, we can reduce stigma and ensure that maternal mental health is treated with the same seriousness as physical complications.
Postpartum recovery: physical rehabilitation and complications management
The postpartum period, often referred to as the “fourth trimester”, is a critical yet frequently neglected phase of maternal health. After the intense focus on pregnancy and birth, many women find that support quickly diminishes just as they are grappling with physical recovery, sleep deprivation and the demands of caring for a newborn. Comprehensive postpartum care should therefore include systematic assessment of physical healing, breastfeeding support, contraception counselling and mental health review.
From a physiological perspective, the maternal body undergoes rapid changes in the first six weeks after birth, with ongoing adjustments for months afterwards. Monitoring these changes can help distinguish normal recovery from emerging complications. In practice, this means scheduled postnatal visits, clear guidance on warning signs, and accessible pathways to specialist care when needed.
Involution of the uterus and lochia assessment
Following delivery, the uterus begins a process of involution, gradually returning to its pre-pregnancy size over approximately six weeks. This is accompanied by lochia, a discharge that changes from bright red to pink, then brown and finally yellow-white as healing progresses. Regular assessment of uterine size and lochia characteristics – whether in hospital or at home visits – provides important clues about recovery and the risk of infection or haemorrhage.
Excessive bleeding, foul-smelling lochia, or severe abdominal pain warrant prompt medical review. Educating women about what to expect, and when to seek help, can be life-saving. You might think of lochia as the body’s “healing signature”; when the pattern deviates significantly from the norm, it signals that closer attention is required.
Perineal trauma healing: episiotomy and tear management
Perineal trauma, whether from spontaneous tears or episiotomy, is common in vaginal birth and can significantly affect comfort, mobility and sexual function. Proper wound care, pain management and pelvic floor support are therefore key elements of postpartum rehabilitation. Simple measures such as regular perineal hygiene, use of cold packs, and appropriate analgesia can ease discomfort in the first days after birth.
For more severe tears, particularly third- and fourth-degree injuries involving the anal sphincter, specialist follow-up is essential to monitor healing, continence and pelvic floor function. Early referral to physiotherapy can support muscle recovery and reduce long-term complications. Open conversations about perineal pain and sexual health help counter the tendency for women to “suffer in silence” and reinforce that their comfort and dignity matter.
Lactation support: breastfeeding establishment and mastitis prevention
Breastfeeding offers substantial health benefits for both mother and baby, yet many women encounter challenges in the early days and weeks. Effective lactation support focuses on optimising positioning and latch, responding to infant feeding cues, and managing common issues such as nipple pain, engorgement and perceived low milk supply. Skilled guidance, whether from midwives, lactation consultants or peer supporters, can make the difference between a positive experience and early cessation.
Mastitis – inflammation or infection of the breast – often arises from milk stasis, poor drainage or nipple damage. Preventive strategies include frequent, effective feeds, avoiding tight clothing, and addressing latch problems promptly. If mastitis does occur, early treatment with rest, continued feeding, and antibiotics when indicated usually leads to rapid resolution. Supporting lactation is not only about infant nutrition; it is also a core component of maternal health after pregnancy.
Postpartum haemorrhage prevention: uterotonic administration protocols
Postpartum haemorrhage (PPH) remains one of the leading causes of maternal mortality worldwide. Active management of the third stage of labour, including the prophylactic administration of uterotonic drugs such as oxytocin, has been shown to significantly reduce PPH incidence. Standard protocols typically involve giving a uterotonic immediately after birth, controlled cord traction, and careful uterine massage as needed.
Beyond the delivery room, vigilant monitoring of blood loss, vital signs and uterine tone in the hours following birth is crucial. In settings with limited resources, training birth attendants in PPH recognition and first-line management, including the use of misoprostol where injectable oxytocin is unavailable, can save lives. For women and families, understanding that rapid, heavy bleeding after birth is an emergency helps ensure they seek urgent care without delay.
Long-term maternal health outcomes: cardiovascular and metabolic disease risk
The impact of pregnancy on maternal health does not end with childbirth or even the first postpartum year. Increasing evidence shows that pregnancy complications such as gestational diabetes, pre-eclampsia and preterm birth are powerful predictors of future cardiovascular and metabolic disease. In this sense, pregnancy acts as an early “stress test” for the heart, blood vessels and metabolic system, revealing susceptibilities that might otherwise remain hidden for decades.
Recognising these links transforms how we should approach follow-up care. Rather than discharging women from maternity services with no further plan, there is a strong argument for structured, long-term monitoring and prevention strategies. Lifestyle optimisation, regular screening for blood pressure and glucose abnormalities, and clear communication with primary care providers can all help reduce the burden of chronic disease in women who have experienced complicated pregnancies.
Type 2 diabetes mellitus development Post-Gestational diabetes
Women who develop gestational diabetes are at substantially increased risk of progressing to type 2 diabetes in the years after pregnancy, with estimates suggesting that up to 50% may do so within 10 years if no preventive measures are taken. This elevated risk persists even if blood glucose appears to normalise soon after birth, underscoring the need for ongoing surveillance. Postpartum glucose tolerance testing at 6–12 weeks, followed by regular screening every one to three years, is widely recommended.
From a practical standpoint, lifestyle interventions focusing on diet quality, weight management and physical activity are highly effective in reducing the transition from gestational to type 2 diabetes. Supportive programmes that involve the whole family can make changes more sustainable – after all, healthier eating and regular movement benefit partners and children too. By reframing gestational diabetes as an early warning sign rather than a transient complication, we can help women take proactive steps to protect their long-term health.
Hypertensive disorders and future cardiovascular disease correlation
Hypertensive disorders of pregnancy, including gestational hypertension and pre-eclampsia, are now recognised as independent risk factors for later cardiovascular disease. Women with these conditions have higher rates of chronic hypertension, ischaemic heart disease, stroke and heart failure in midlife compared with those who had normotensive pregnancies. The exact mechanisms are complex, involving endothelial dysfunction, metabolic alterations and genetic predisposition.
For clinicians and women alike, the key message is that a history of pre-eclampsia or gestational hypertension should trigger earlier and more frequent cardiovascular risk assessment. This may include regular blood pressure checks, lipid profiles, and counselling on smoking cessation, exercise and diet. In effect, pregnancy becomes an invaluable “preview” of future cardiovascular health, offering a unique opportunity for early intervention.
Maternal obesity: BMI impact on pregnancy complications and future health
Maternal obesity, typically defined as a body mass index (BMI) of 30 kg/m² or higher, is associated with a broad range of pregnancy complications, including gestational diabetes, hypertensive disorders, caesarean delivery and postpartum haemorrhage. It also increases the risk of sleep apnoea, thromboembolism and anaesthetic complications. For the child, maternal obesity is linked with higher rates of stillbirth, congenital anomalies and later-life obesity and metabolic disease.
Importantly, obesity also has profound implications for women’s long-term health beyond pregnancy, amplifying the risk of type 2 diabetes, cardiovascular disease, certain cancers and musculoskeletal problems. Addressing weight and lifestyle before conception, between pregnancies and in the postpartum period can therefore yield significant benefits. Supportive, non-stigmatising interventions that focus on realistic, sustainable changes – rather than rapid weight loss – are most likely to succeed. Ultimately, prioritising maternal health during and after pregnancy is not only about surviving childbirth; it is about laying the groundwork for a lifetime of better health for women and their families.